RecruitingNot Applicable

Discontinuation of Antithrombotic Treatment Following Patent Foramen Ovale Closure in Young Patients With Cryptogenic Stroke

Canada100 participantsStarted 2020-07-08

Plain-language summary

To determine the safety of antithrombotic treatment discontinuation 12 months following successful transcatheter PFO closure.

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Presence of new stroke events

Timeframe: 12 months

Presence of new ischemic lesions

Timeframe: 24-month follow-up

NCT IDNCT04475510

SponsorJosep Rodes-Cabau

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-01

Josep Rodes-Cabau, MD